Celsion Corp.’s CLSN shares have rallied almost 20% on Wednesday after ... the Zacks classified Medical-Biomed/Genetics industry so far this year. The stock has plunged 43.1% compared with the broader industry’s …
ticker=CLSN Nektar Therapeutics https://rdinvesting.com/news/?ticker=NKTR Celsion Corporation shares closed up 6% on Monday with a little over 6 million shares traded. The stock soared after the company announced that it has submitted …
Celsion Corp. (CLSN) presented the final data from its Phase Ib clinical ... Tuesday's session and finished up by 4.55 at $6.06 on the highest volume of the year. The stock surged to over a 7-month high.
Celsion Corporation CLSN announced results from phase Ib study — OVATION ... Investors cheered the news as the stock skyrocketed over 300% on Tuesday. In fact, shares of the company have surged 42.4% so far this year, …
The stock fell 0.6% in premarket trading ... of the vulnerabilities in its semiconductors but before it was publicly disclosed. Celsion Corp.(CLSN) jumped 18% in premarket trading after the Food and Drug Administration cleared its ovarian …
Celsion Corp. (NASDAQ: CLSN) watched its shares make an incredible gain on Tuesday ... and hard (fundraising activities and dilution that have hit the stock) road to potentially finally finding OPTIMA(L) redemption. We advise investors who …
Mr. Jeffrey W. Church , CPA., is Chief Financial Officer, Senior Vice President, Corporate Secretary and IR Contact Officer of Celsion Corporation. Mr. Church was appointed as Senior Vice President, Corporate Strategy and Investor Relations …
If you want a Stock Review on CLSN, CORT, CTRV, or CUR then come over to http://dailystocktracker.com/register/ …